Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis

Figure 4

Comparison of the reduction of serum LDL-C (%) from baseline between control group and experimental group.